Yamada KH[au] - Search Results

Year	Number of Results
2007	2
2012	1
2014	1
2016	1
2017	1
2018	1
2021	2
2022	2
2023	3
2024	0

1

KIF13B mediates VEGFR2 recycling to modulate vascular permeability.

Cho HD, Nhàn NTT, Zhou C, Tu K, Nguyen T, Sarich NA, Yamada KH. Cho HD, et al. Among authors: yamada kh. Cell Mol Life Sci. 2023 Mar 16;80(4):91. doi: 10.1007/s00018-023-04752-5. Cell Mol Life Sci. 2023. PMID: 36928770 Free PMC article.

2

Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides.

Nhàn NTT, Maidana DE, Yamada KH. Nhàn NTT, et al. Among authors: yamada kh. Cells. 2023 Apr 1;12(7):1071. doi: 10.3390/cells12071071. Cells. 2023. PMID: 37048144 Free PMC article. Review.

3

Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.

Nhàn NTT, Yamada T, Yamada KH. Nhàn NTT, et al. Among authors: yamada kh. Int J Mol Sci. 2023 Aug 18;24(16):12931. doi: 10.3390/ijms241612931. Int J Mol Sci. 2023. PMID: 37629112 Free PMC article. Review.

4

KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo.

Waters SB, Dominguez JR, Cho HD, Sarich NA, Malik AB, Yamada KH. Waters SB, et al. Among authors: yamada kh. Life Sci Alliance. 2021 Oct 20;5(1):e202101170. doi: 10.26508/lsa.202101170. Print 2022 Jan. Life Sci Alliance. 2021. PMID: 34670814 Free PMC article.

5

A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration.

Yamada KH. Yamada KH. Neural Regen Res. 2022 Aug;17(8):1751-1752. doi: 10.4103/1673-5374.332147. Neural Regen Res. 2022. PMID: 35017431 Free PMC article. No abstract available.

6

VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.

Waters SB, Zhou C, Nguyen T, Zelkha R, Lee H, Kazlauskas A, Rosenblatt MI, Malik AB, Yamada KH. Waters SB, et al. Among authors: yamada kh. Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):5. doi: 10.1167/iovs.62.2.5. Invest Ophthalmol Vis Sci. 2021. PMID: 33533881 Free PMC article.

7

Characterization of phenyl pyrimidine derivatives that inhibit cytomegalovirus immediate-early gene expression.

Yamada KH, Majima R, Yamaguchi T, Inoue N. Yamada KH, et al. Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618763193. doi: 10.1177/2040206618763193. Antivir Chem Chemother. 2018. PMID: 29546767 Free PMC article.

8

KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2.

Yamada KH, Nakajima Y, Geyer M, Wary KK, Ushio-Fukai M, Komarova Y, Malik AB. Yamada KH, et al. J Cell Sci. 2014 Oct 15;127(Pt 20):4518-30. doi: 10.1242/jcs.156109. Epub 2014 Aug 15. J Cell Sci. 2014. PMID: 25128562 Free PMC article.

9

[Transport of PIP3 mediated by kinesin regulates neuronal cell polarity].

Yamada KH, Hanada T, Chishti AH. Yamada KH, et al. Tanpakushitsu Kakusan Koso. 2007 Jul;52(8):893-9. Tanpakushitsu Kakusan Koso. 2007. PMID: 17642273 Review. Japanese. No abstract available.

10

Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells.

Yamada KH, Kang H, Malik AB. Yamada KH, et al. Am J Pathol. 2017 Jan;187(1):214-224. doi: 10.1016/j.ajpath.2016.09.010. Epub 2016 Nov 15. Am J Pathol. 2017. PMID: 27863212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year